Bonnie Wang

Bonnie Wang, MS, DABT, has extensive experience in clinical pharmacology, drug disposition, and toxicokinetics, primarily at Bristol Myers Squibb since March 2004. Currently serving as Associate Director of Clinical Pharmacology and Pharmacometrics, Bonnie contributes to compound development across various phases, representing Clinical Pharmacology in governance meetings, and leading clinical study design and data analysis. Previous roles include Associate Director/Senior Principal Scientist, overseeing nonclinical DMPK programs and managing strategic planning for drug development teams, and Principal Scientist/Manager, providing oversight on toxicokinetic data analysis and study design optimization. Earlier experience includes serving as Staff Chemist at Merck and Research Scientist at ABC Laboratories, where Bonnie conducted critical pharmacokinetics and drug metabolism studies. Educational qualifications include an MS in Pharmacometrics from the University of Maryland, Baltimore, an MS in Nutrition from the University of Missouri-Columbia, and multiple degrees in Molecular Biology from Nankai University and the Institute of Biophysics, Chinese Academy of Sciences.